Standout Papers

Metastatic non-small cell lung cancer: E... 2007 2026 2013 2019 1.5k
  1. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (2018)
    David Planchard, Sanjay Popat et al. Annals of Oncology
  2. Small-cell lung cancer (2021)
    Charles M. Rudin, Élisabeth Brambilla et al. Nature Reviews Disease Primers
  3. Prophylactic Cranial Irradiation in Extensive Small-Cell Lung Cancer (2007)
    Ben J. Slotman, Corinne Faivre‐Finn et al. New England Journal of Medicine
  4. ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy) (2009)
    Alessandro Brunelli, Anne Charloux et al. European Respiratory Journal
  5. Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial (2016)
    P. Mulvenna, Matthew Nankivell et al. The Lancet
  6. Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial (2014)
    Ben J. Slotman, Harm van Tinteren et al. The Lancet
  7. Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial (2017)
    Corinne Faivre‐Finn, M. Snee et al. The Lancet Oncology
  8. Three-Year Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC—Update from PACIFIC (2019)
    Jhanelle E. Gray, Augusto Villegas et al. Journal of Thoracic Oncology
  9. Thymic epithelial tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (2015)
    Nicolas Girard, Enrico Ruffini et al. Annals of Oncology
  10. Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆ (2021)
    Anne‐Marie C. Dingemans, Martin Früh et al. Annals of Oncology
  11. Non-small-cell lung cancer (2024)
    Lizza Hendriks, Jordi Remón et al. Nature Reviews Disease Primers

Immediate Impact

3 by Nobel laureates 12 from Science/Nature 77 standout
Sub-graph 1 of 21

Citing Papers

Dual-Locked Fluorescence Probe for Monitoring the Dynamic Transition of Pulmonary Macrophages
2025 Standout
A vision–language foundation model for precision oncology
2025 StandoutNature
1 intermediate paper

Works of Corinne Faivre‐Finn being referenced

Five-year survival outcomes with durvalumab after chemoradiotherapy in unresectable stage III NSCLC: An update from the PACIFIC trial.
2021
Small-cell lung cancer
2021 Standout

Author Peers

Author Last Decade Papers Cites
Corinne Faivre‐Finn 8582 7229 2425 2816 388 13.9k
Theodore L. Phillips 8037 4645 3371 1909 309 16.2k
Anne‐Marie C. Dingemans 5492 4688 1825 1443 361 9.8k
Andrea Bezjak 10201 7982 2666 1118 318 16.8k
Jan P. van Meerbeeck 10705 5518 1894 1418 371 15.1k
James R. Jett 9927 6745 3114 2368 275 16.3k
Danny Rischin 6132 7613 2233 1115 364 15.0k
Theodore S. Hong 4200 6404 1497 1408 359 10.6k
Stephanie E. Combs 6164 2100 3675 2732 496 13.0k
Laurie E. Gaspar 15604 8456 2763 3179 243 19.4k
Yuta Shibamoto 5342 2400 2593 1490 552 10.9k

All Works

Loading papers...

Rankless by CCL
2026